GlaxoSmithKline Pharmaceuticals board recommends dividend

19 May 2017 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on May 19, 2017, has recommended a dividend of 300% on the Equity Share capital i.e. Rs 30 per equity share for the year ended March 31, 2017. The dividend if approved by the shareholders will be paid after July 25, 2017.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2132.75 67.35 (3.26%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.